Macquarie gives #39;outperform#39; rating to Mankind Pharma, sees 30% upside

Brokerage firm Macquarie Research has given Mankind Pharma Ltd an outperform rating with a target price of Rs 1400 per share, indicating a potential upside of 29.6% from its issue price of Rs 1068 per share.

source https://www.moneycontrol.com/news/buzzing-stocks/macquarie-gives-39outperform39-rating-to-mankind-pharma-sees-30-upside_16990621.html